A phase I, first-in-human clinical trial of the GDF-15 neutralizing antibody CTL-002 in subjects with advanced stage solid tumors (acronym: GDFATHER)

Autores: Melero Bermejo, Ignacio; Calvo, E.; Goebeler, M. E.; Garralda, E.; Dummer, R.; Rodríguez Ruiz, María Esperanza; De Miguel, M.; Sayehli, C. M.; Alonso Casal, G.; Ramelyte, E.; Schuler, M.; Gromke, T.; Fernández de Sanmamed Gutiérrez, Miguel; Moreno, I.; Bargou, R.; Lostes, M.; Maul, J. T.; Eggenschwiler, C.; Richly, H.; Fettes, P.; Klar, K.; Schuberth-Wagner, C.; Haake, M.; Wischhusen, J.; Leo, E.